ArticleNPJ digital medicine2026
Anonymization and visualization of health data and biomarkers.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Access to large, diverse biomedical datasets is critical for advancing medical research, yet privacy regulations severely restrict data sharing. We present an end-to-end framework for privacy-preserving health data synthesis that integrates advanced deep generative models (DGMs) with robust preprocessing, formal differential privacy (DP) training for select DGMs, empirical privacy risk evaluation, data-sufficiency analysis, domain-guided quality control, and biobank visualization tools. Released as open-source containerized software, the framework ensures reproducible deployment while preserving statistical fidelity, machine learning (ML) utility, and privacy guarantees. Empirical evaluations across diverse biobank datasets demonstrate that TabSyn-a transformer-based diffusion model-combined with our correlation-and distribution-aware CorrDst loss function achieves superior performance balancing fidelity, privacy, and computational efficiency. The tailored preprocessing pipeline effectively handles high missingness rates, substantially improving distributional accuracy and clinical plausibility. Across 26 biobank datasets spanning three regulatory levels, the framework shows that TabSyn with correlation- and distribution-aware loss function consistently achieves superior performance in terms of fidelity, privacy, and computational efficiency.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.